Optos, a developer of advanced retinal imaging technology, is among the recipients of the 2019 Queen’s Awards for Enterprise. The Fife, Scotland-based company is being recognized for its advancements in retinal imaging technology. “To be recognized by such a prestigious business award is a great achievement for the entire team in the U.K. and across Europe, North America, Asia, and Australia,” said Optos CEO Robert Kennedy. “It is a testament to their efforts to provide our customers with the best devices to support their clinical care and help to improve practice efficiency. Most of all, it reinforces our commitment to keep innovating in the fight against vision loss.” The award specifically acknowledges Optos’ California retinal imager, which is designed to help manage eye-related conditions such as age-related macular degeneration. “The California device has continued to strengthen the position of Optos at the forefront of the global retinal imaging market,” Kennedy said. “The innovative technology within the device provides superior imaging which had been demonstrated in over 600 clinical studies to aid the enhancement of patient care.” Optos specializes in ultrawide-field retinal imaging technology for ophthalmology applications. According to the company, the imaging technology provides optometrists and ophthalmologists with a bigger picture and more clinical information to assist with “the early detection, management, and effective treatment of disorders and diseases evidenced in the retina, such as retinal detachments and tears, glaucoma, diabetic retinopathy, and age-related macular degeneration.”